JP2008514639A5 - - Google Patents

Download PDF

Info

Publication number
JP2008514639A5
JP2008514639A5 JP2007533754A JP2007533754A JP2008514639A5 JP 2008514639 A5 JP2008514639 A5 JP 2008514639A5 JP 2007533754 A JP2007533754 A JP 2007533754A JP 2007533754 A JP2007533754 A JP 2007533754A JP 2008514639 A5 JP2008514639 A5 JP 2008514639A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
alkynyl
acyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007533754A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008514639A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/034786 external-priority patent/WO2006037028A2/en
Publication of JP2008514639A publication Critical patent/JP2008514639A/ja
Publication of JP2008514639A5 publication Critical patent/JP2008514639A5/ja
Pending legal-status Critical Current

Links

JP2007533754A 2004-09-24 2005-09-26 フラビウイルス、ペスチウイルス及びヘパシウイルスの感染症を治療するための方法及び組成物 Pending JP2008514639A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61308504P 2004-09-24 2004-09-24
PCT/US2005/034786 WO2006037028A2 (en) 2004-09-24 2005-09-26 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus

Publications (2)

Publication Number Publication Date
JP2008514639A JP2008514639A (ja) 2008-05-08
JP2008514639A5 true JP2008514639A5 (cg-RX-API-DMAC7.html) 2008-11-13

Family

ID=36119563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007533754A Pending JP2008514639A (ja) 2004-09-24 2005-09-26 フラビウイルス、ペスチウイルス及びヘパシウイルスの感染症を治療するための方法及び組成物

Country Status (12)

Country Link
US (1) US20080280850A1 (cg-RX-API-DMAC7.html)
EP (1) EP1804811A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008514639A (cg-RX-API-DMAC7.html)
KR (1) KR20070073805A (cg-RX-API-DMAC7.html)
CN (1) CN101072570A (cg-RX-API-DMAC7.html)
AU (1) AU2005289517A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515896A (cg-RX-API-DMAC7.html)
CA (1) CA2581523A1 (cg-RX-API-DMAC7.html)
IL (1) IL182061A0 (cg-RX-API-DMAC7.html)
NO (1) NO20072055L (cg-RX-API-DMAC7.html)
RU (1) RU2007115419A (cg-RX-API-DMAC7.html)
WO (1) WO2006037028A2 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
PL359169A1 (en) 2000-05-26 2004-08-23 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
KR20050035194A (ko) 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
RU2358979C2 (ru) 2003-05-30 2009-06-20 Фармассет, Инк. Модифицированные фторированные аналоги нуклеозида
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
ES2725457T3 (es) 2004-09-14 2019-09-24 Gilead Pharmasset Llc Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
KR101806314B1 (ko) 2008-04-03 2017-12-07 스프링 뱅크 파마슈티칼스, 인크. 바이러스 감염증을 치료하기 위한 조성물 및 방법
MX2011006890A (es) 2008-12-23 2011-07-20 Pharmasset Inc Analogos de nucleosidos.
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
HRP20180237T4 (hr) 2011-09-16 2020-12-11 Gilead Pharmasset Llc Metode za liječenje hcv-a
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CN103833812A (zh) * 2012-11-23 2014-06-04 中国人民解放军军事医学科学院毒物药物研究所 吡嗪衍生物及其医药用途
EP2950786B1 (en) 2013-01-31 2019-11-27 Gilead Pharmasset LLC Combination formulation of two antiviral compounds
JP6521967B2 (ja) 2013-08-06 2019-05-29 イマーゴ バイオサイエンシーズ インコーポレイテッド 疾患の治療のためのkdm1a阻害剤
EA201690473A1 (ru) 2013-08-27 2017-03-31 ГАЙЛИД ФАРМАССЕТ ЭлЭлСи Комбинированный состав двух противовирусных соединений
CN105732748B (zh) * 2014-12-12 2019-01-01 浙江医药股份有限公司新昌制药厂 一种核苷酸类似物及其制备方法、以及含有核苷酸类似物的药物组合物及其应用
JP6727216B2 (ja) 2015-02-12 2020-07-22 イマーゴ バイオサイエンシーズ インコーポレイテッド 疾患の治療のためのkdm1a阻害剤
CN111194306B (zh) 2016-08-16 2023-05-16 伊美格生物科学公司 用于制备kdm1a抑制剂的方法和过程
JP7450559B2 (ja) * 2018-05-11 2024-03-15 イマーゴ バイオサイエンシーズ インコーポレイテッド 疾患の処置のためのkdm1a阻害剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134066A (en) * 1989-08-29 1992-07-28 Monsanto Company Improved probes using nucleosides containing 3-dezauracil analogs
DE60108724T2 (de) * 2000-02-16 2005-06-23 Toyama Chemical Co. Ltd. Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
CA2456292A1 (en) * 2001-08-14 2003-02-27 Toyama Chemical Co., Ltd. Novel virus growth inhibitor and/or virucidal method, and novel pyrazine nucleotide or pirazine nucleoside analog
US7323453B2 (en) * 2002-02-13 2008-01-29 Merck & Co., Inc. Methods of inhibiting orthopoxvirus replication with nucleoside compounds
RU2004128943A (ru) * 2002-02-28 2005-04-20 Байота, Инк. (Us) Средства, имитирующие нуклеотиды, и их пролекарственные формы
BR0309581A (pt) * 2002-05-06 2005-03-29 Genelabs Tech Inc Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
WO2003105770A2 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
US20060234962A1 (en) * 2002-06-27 2006-10-19 Olsen David B Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
AU2003247084B9 (en) * 2002-06-28 2018-07-26 Centre National De La Recherche Scientifique Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
KR20050035194A (ko) * 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
JP4398631B2 (ja) * 2002-07-12 2010-01-13 富山化学工業株式会社 新規なピラジン誘導体またはその塩並びにそれらを含有する抗ウイルス剤
EP1556399A4 (en) * 2002-07-16 2007-09-26 Merck & Co Inc Nucleoside derivatives as inhibitors of RNA-dependent viral RNA polymerase
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
AU2003298658A1 (en) * 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation

Similar Documents

Publication Publication Date Title
RU2007115419A (ru) Способы и композиции для лечения флавивирусов, пестивирусов и гепацивируса
CA2490191A1 (en) Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections
JP2007501185A5 (cg-RX-API-DMAC7.html)
RU2006105640A (ru) Аналоги пуриновых нуклеозидов для лечения flaviviridae, включая гепатит с
JP2004533401A5 (cg-RX-API-DMAC7.html)
CA2954751C (en) Indoles for use in influenza virus infection
RU2428428C9 (ru) Серусодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
Abdou et al. Phosphinic acids: current status and potential for drug discovery
JP2009504764A5 (cg-RX-API-DMAC7.html)
JP2004510698A5 (cg-RX-API-DMAC7.html)
RU2005141176A (ru) Модифицированые фторированные аналоги нуклеозида
JP2009504763A5 (cg-RX-API-DMAC7.html)
CA2409613A1 (en) Methods and compositions for treating hepatitis c virus
RU2012132218A (ru) Соединения и фармацевтические композиции для лечения вирусных инфекций
JP2005519916A5 (cg-RX-API-DMAC7.html)
JP2004513881A5 (cg-RX-API-DMAC7.html)
CA2410579A1 (en) Methods and compositions for treating flaviviruses and pestiviruses
JP2019507774A5 (cg-RX-API-DMAC7.html)
JP2002539128A5 (cg-RX-API-DMAC7.html)
RU2018127728A (ru) Слитые трициклические гетероциклические соединения в качестве ингибиторов интегразы вич
JP2014520822A5 (cg-RX-API-DMAC7.html)
JP2013056886A5 (cg-RX-API-DMAC7.html)
JP2008530240A5 (cg-RX-API-DMAC7.html)
JP2008517923A5 (cg-RX-API-DMAC7.html)
AU2025201936A1 (en) Compositions In The Form Of An Injectable Aqueous Solution Comprising Human Glucagon And A Copolyamino Acid